This report offers an in-depth examination of Saudi Arabia’s healthcare system as it evolves to meet the Kingdom’s Vision 2030 goals. Key areas covered include:

Regulatory and Pricing: The process for approving medications, how prices are determined including factors influencing pricing decisions

HTA and National Reimbursement: The evolution of Saudi’s Health Technology Assessment process and how this introduces the concept of national reimbursement in Saudi Arabia

Access: How individuals access healthcare services and medications, the role of hospital formularies and early access programs

Procurement: The main entities and mechanisms for procuring therapies and medical supplies for the public healthcare system

Future Outlook: Key trends and anticipated evolution of Saudi Arabia’s healthcare market and pharmaceutical sector